← All organizations

Gruppo Italiano Trapianto di Midollo Osseo

Academic/HospitalWebsite ↗

Also known as: Gruppo Italiano Trapianto di Midollo Osseo

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 30, 2020

Timeline

1980s

Jan 1, 1987
Gruppo Italiano Trapianto di Midollo Osseo— Founded

Drugs by trial phase (18 distinct, 8 trials)

Phase 3 (10 own, 0 via acquisition)

Phase 2 (7 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

nilotinib

Indications

Studied for

Recent trials (8)

NCT04476199Lead sponsorPhase 2Nov 30, 2020
NCT03270748Lead sponsorPhase 2Oct 1, 2018
NCT03494959Lead sponsorPhase 2Sep 1, 2018
NCT01810718Lead sponsorPhase 1Nov 1, 2011
NCT01814475Lead sponsorPhase 2Jul 1, 2011
NCT01191957Lead sponsorPhase 3Jan 1, 2008
NCT00354120Lead sponsorPhase 2/Phase 3Mar 1, 2005
NCT00435955CollaboratorPhase 3Mar 1, 2000

Details

Founded: IT Jan 1, 1987
Last known activity: Nov 30, 2020